With an annual growth rate in excess of 10%, the life sciences are one of the strongest industrial sectors in Switzerland. The research results and inventions generated by universities can make a major contribution to the progress in life sciences if they are transferred to industrial companies and developed into marketable products and services. In particular the establishment of new companies – spin-offs or start-ups – ensures that the results of research are turned into innovative medical products and that new jobs are created.
USI, with its Center of Advanced Studies on Entrepreneurship in BioMedicine (CASE Biomed) was, in 2010, the first academic institution in Switzerland to offer a series of leading-edge comprehensive advanced programmes – BioBusiness, MedTech Business, BioClub – providing young life sciences companies with the theoretical and project-based practical skills needed to develop, fund and market biomedical innovations.
CASE BioMed is an autonomous structure within the USI Faculty of Biomedical Sciences, which also contributes to complete the scientific and biomedical education provided by the Faculty.